LEANA CHIEN: Open Payments
NPI 1215252010 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 12 payments from 10 companies in 2025. Trend: 2023 $408 · 2024 $443 · 2025 $1,137
Food & beverage: $1,038Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $235 |
| Gilead Sciences, Inc. | 1 | $135 |
| Karyopharm Therapeutics Inc. | 1 | $128 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| PFIZER INC. | 2 | $124 |
| Syndax Pharmaceuticals, Inc. | 1 | $120 |
| SEAGEN INC. | 1 | $99 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Eisai Inc. | 1 | $18 |
Products named: XPOVIO, PYRUKYND, OPDIVO, REVUFORJ, DATROWAY, ADCETRIS, TIVDAK, ZEPZELCA.
Industry payments across CA — which companies pay providers there.
